H/T to reader Real Limey for this.
Background: Shares in Meldex were suspended in December 2008 as the Cambridge-based drug company told investors it was “seeking to clarify its trading and working capital position”.
A year later and the full story has now emerged and it is not pretty.
Here are just a few of the lowlights from the Meldex’s Financial Statements for the year ended 31 December, 2008.
The rest of this sorry tale can be found here.
In June, Meldex started legal proceedings against former chief executive Richard Trevillion and chief development officer Mr Steven Martin.
Its shares were eventually delisted from Aim in March at just 6p.
Related link:
More fun and games on Aim – FT Alphaville
Resurrecting Meldex – Investors Chronicle